-+ 0.00%
-+ 0.00%
-+ 0.00%

PAVmed subsidiary Lucid Diagnostics closes $18 million common stock offering

PUBT·04/24/2026 14:29:28
Listen to the news
PAVmed subsidiary Lucid Diagnostics closes $18 million common stock offering
  • Lucid Diagnostics, PAVmed subsidiary, closed underwritten registered direct offering of 18,000,000 common shares at USD 1 per share.
  • Gross proceeds totaled about USD 18 million, anchored by USD 15 million from a fundamental institutional investor.
  • Net proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PAVmed Inc. published the original content used to generate this news brief on April 24, 2026, and is solely responsible for the information contained therein.